Skyrizi

Risankizumab-Rzaa

8.3 High risk

Skyrizi & Psoriasis

6.8%

of users reported Psoriasis

65.5%

also reported Severe reaction

58.2%

are women

Most common medical consequences

Severe reaction
65.5%
Hospitalization
32.6%
Disability
1.2%
Birth Defects
0.3%
Medical Intervention
0.3%

Have you experienced any negative side effects from this medication?

Skyrizi: general information

Most common side effects (262)

Most commonly affected ages

10 - 19 years
0.3%
20 - 29 years
3.2%
30 - 39 years
9.5%
40 - 49 years
13.2%
50 - 59 years
24.7%
60 - 69 years
29.2%
70 - 79 years
15.8%
80 - 89 years
4.2%